M B Davidson

Summary

Affiliation: Charles R. Drew University of Medicine and Science
Country: USA

Publications

  1. ncbi A stepwise approach to insulin therapy in patients with type 2 diabetes mellitus and basal insulin treatment failure
    Mayer B Davidson
    Charles Drew University, Los Angeles, CA, USA
    Endocr Pract 17:395-403. 2011
  2. ncbi High-dose vitamin D supplementation in people with prediabetes and hypovitaminosis D
    Mayer B Davidson
    Department of Internal Medicine, Division of Endocrinology, Metabolism and Molecular Medicine, Charles R Drew University, Los Angeles, CA, USA
    Diabetes Care 36:260-6. 2013
  3. ncbi The dilemma of self-monitoring of blood glucose
    M B Davidson
    Clinical Center for Research Excellence, Charles R. Drew University, 1731 East 120th Street, Los Angeles, CA 90059, USA
    Diabetologia 50:497-9. 2007
  4. ncbi The effectiveness of nurse- and pharmacist-directed care in diabetes disease management: a narrative review
    Mayer B Davidson
    Clinical Center for Research Excellence, Charles R Drew University, 1731 East 120th Street, Los Angeles, CA 90059, USA
    Curr Diabetes Rev 3:280-6. 2007
  5. ncbi Pro's and con's of the early use of insulin in the management of type 2 diabetes: a clinical evaluation
    Mayer B Davidson
    Clinical Center for Research Excellence, Charles Drew University, Los Angeles, California 90059, USA
    Curr Opin Endocrinol Diabetes Obes 16:107-12. 2009
  6. ncbi U-500 regular insulin: clinical experience and pharmacokinetics in obese, severely insulin-resistant type 2 diabetic patients
    Mayer B Davidson
    Department of Internal Medicine, Charles Drew University, Los Angeles, California, USA
    Diabetes Care 33:281-3. 2010
  7. ncbi Detailed treatment algorithms for effective nurse- and pharmacist-directed diabetes care: a personal approach
    Mayer B Davidson
    Clinical Center for Research Excellence, Charles R Drew University, 1731 East 120th Street, Los Angeles, CA 90059, USA
    Diabetes Educ 35:61-71. 2009
  8. ncbi Effect of age and race/ethnicity on HbA1c levels in people without known diabetes mellitus: implications for the diagnosis of diabetes
    Mayer B Davidson
    Clinical Center for Research Excellence, Charles Drew University, 1731 East 120th Street, Los Angeles, CA 90059, United States
    Diabetes Res Clin Pract 87:415-21. 2010
  9. ncbi Evaluation of self monitoring of blood glucose in non-insulin-treated diabetic patients by randomized controlled trials: little bang for the buck
    Mayer B Davidson
    Charles Drew University, Los Angeles, CA 90059, USA
    Rev Recent Clin Trials 5:138-42. 2010
  10. ncbi Integrating nurse-directed diabetes management into a primary care setting
    Mayer B Davidson
    Department of Internal Medicine, Charles R Drew University of Medicine and Science, Los Angeles, CA 90059, USA
    Am J Manag Care 16:652-6. 2010

Detail Information

Publications70

  1. ncbi A stepwise approach to insulin therapy in patients with type 2 diabetes mellitus and basal insulin treatment failure
    Mayer B Davidson
    Charles Drew University, Los Angeles, CA, USA
    Endocr Pract 17:395-403. 2011
    ..To determine whether 1 or 2 preprandial injections before the meals of greatest glycemic impact can be as effective as 3 preprandial injections in patients with type 2 diabetes mellitus and basal insulin treatment failure...
  2. ncbi High-dose vitamin D supplementation in people with prediabetes and hypovitaminosis D
    Mayer B Davidson
    Department of Internal Medicine, Division of Endocrinology, Metabolism and Molecular Medicine, Charles R Drew University, Los Angeles, CA, USA
    Diabetes Care 36:260-6. 2013
    ..This double-blind, randomized, control study in subjects with prediabetes and hypovitaminosis D evaluated whether high doses of vitamin D for 1 year affected insulin secretion, insulin sensitivity, and the development of diabetes...
  3. ncbi The dilemma of self-monitoring of blood glucose
    M B Davidson
    Clinical Center for Research Excellence, Charles R. Drew University, 1731 East 120th Street, Los Angeles, CA 90059, USA
    Diabetologia 50:497-9. 2007
  4. ncbi The effectiveness of nurse- and pharmacist-directed care in diabetes disease management: a narrative review
    Mayer B Davidson
    Clinical Center for Research Excellence, Charles R Drew University, 1731 East 120th Street, Los Angeles, CA 90059, USA
    Curr Diabetes Rev 3:280-6. 2007
    ....
  5. ncbi Pro's and con's of the early use of insulin in the management of type 2 diabetes: a clinical evaluation
    Mayer B Davidson
    Clinical Center for Research Excellence, Charles Drew University, Los Angeles, California 90059, USA
    Curr Opin Endocrinol Diabetes Obes 16:107-12. 2009
    ..The underlying reason given is that insulin will slow down the apoptosis of pancreatic beta-cells, which is increased in type 2 diabetes. This review will examine the clinical evidence supporting this recommendation...
  6. ncbi U-500 regular insulin: clinical experience and pharmacokinetics in obese, severely insulin-resistant type 2 diabetic patients
    Mayer B Davidson
    Department of Internal Medicine, Charles Drew University, Los Angeles, California, USA
    Diabetes Care 33:281-3. 2010
    ..To describe the clinical experience and the pharmacokinetics of U-500 regular insulin in severely insulin-resistant obese type 2 diabetic patients...
  7. ncbi Detailed treatment algorithms for effective nurse- and pharmacist-directed diabetes care: a personal approach
    Mayer B Davidson
    Clinical Center for Research Excellence, Charles R Drew University, 1731 East 120th Street, Los Angeles, CA 90059, USA
    Diabetes Educ 35:61-71. 2009
    ....
  8. ncbi Effect of age and race/ethnicity on HbA1c levels in people without known diabetes mellitus: implications for the diagnosis of diabetes
    Mayer B Davidson
    Clinical Center for Research Excellence, Charles Drew University, 1731 East 120th Street, Los Angeles, CA 90059, United States
    Diabetes Res Clin Pract 87:415-21. 2010
    ..To determine if age and race/ethnicity affect HbA1c levels independent of glycemia...
  9. ncbi Evaluation of self monitoring of blood glucose in non-insulin-treated diabetic patients by randomized controlled trials: little bang for the buck
    Mayer B Davidson
    Charles Drew University, Los Angeles, CA 90059, USA
    Rev Recent Clin Trials 5:138-42. 2010
    ..This lack of benefit argues for redirecting these resources into areas of diabetes care where strong evidence exists for improving diabetes outcomes...
  10. ncbi Integrating nurse-directed diabetes management into a primary care setting
    Mayer B Davidson
    Department of Internal Medicine, Charles R Drew University of Medicine and Science, Los Angeles, CA 90059, USA
    Am J Manag Care 16:652-6. 2010
    ....
  11. ncbi Clinical implications of the DREAM Study
    Mayer B Davidson
    Clinical Center for Research Excellence, Charles R. Drew University, 1731 East 120th St, Los Angeles, CA 90059, USA
    Diabetes Care 30:418-20. 2007
  12. ncbi Effect of a nurse-directed diabetes disease management program on urgent care/emergency room visits and hospitalizations in a minority population
    Mayer B Davidson
    Clinical Center for Research Excellence, Charles R Drew University, 1731 East 120th St, Los Angeles, CA 90059, USA
    Diabetes Care 30:224-7. 2007
    ..To evaluate whether nurse-directed diabetes care reduced preventable diabetes-related urgent care/emergency room visits and hospitalizations in a minority population...
  13. ncbi Real world effectiveness of rosiglitazone added to maximal (tolerated) doses of metformin and a sulfonylurea agent: a systematic evaluation of triple oral therapy in a minority population
    Rajiv Roy
    Clinical Trials Unit, Charles R Drew University, Los Angeles, CA 90059, USA
    Diabetes Care 27:1741-2. 2004
  14. ncbi Using focus groups of older African Americans and Latinos with diabetes to modify a self-care empowerment intervention
    Catherine A Sarkisian
    Department of Medicine, Division of Geriatrics, David Geffen School of Medicine at UCLA, Los Angeles, California 90095 1687, USA
    Ethn Dis 15:283-91. 2005
    ..To make cultural and age-specific modifications to a self-care empowerment intervention...
  15. ncbi Effect of a pharmacist-managed diabetes care program in a free medical clinic
    M B Davidson
    Clinical Trials Unit, Charles R Drew University, Los Angeles, CA 90059, USA
    Am J Med Qual 15:137-42. 2000
    ..Pharmacists following detailed algorithms can enhance this care further. Administrative and support system changes that minimize the number of missed visits might further improve diabetes care in this population...
  16. ncbi Clinical experience with U-500 regular insulin in obese, markedly insulin-resistant type 2 diabetic patients
    Piya Ballani
    Clinical Center for Research Excellence, Charles R. Drew University, 1731 E. 120th St, Los Angeles, CA 90059, USA
    Diabetes Care 29:2504-5. 2006
  17. ncbi More evidence to support "outsourcing" of diabetes care
    Mayer B Davidson
    Clinical Trials Unit, Charles R. Drew University, Los Angeles, California 90059, USA
    Diabetes Care 27:995. 2004
  18. ncbi The effect of self monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trial
    Mayer B Davidson
    Clinical Trials Unit, Charles R. Drew University, 1731 East 120th Street, Los Angeles, CA 90059, USA
    Am J Med 118:422-5. 2005
  19. ncbi Effect of Pancreas Tonic (an ayurvedic herbal supplement) in type 2 diabetes mellitus
    Stanley H Hsia
    Charles R. Drew University of Medicine and Science, Los Angeles, CA, USA
    Metabolism 53:1166-73. 2004
    ..0% to 12.0%. This study represents the first properly designed, prospective intervention trial of therapy with an Ayurvedic herbal supplement for intermediate-term glucose control in type 2 diabetes...
  20. ncbi Counterpoint: Self-monitoring of blood glucose in type 2 diabetic patients not receiving insulin: a waste of money
    Mayer B Davidson
    Clinical Trials Unit, Charles R. Drew University, 1731 East 120th St, Los Angeles, CA 90059, USA
    Diabetes Care 28:1531-3. 2005
  21. ncbi Exenatide
    Mayer B Davidson
    Charles R. Drew University, Los Angeles, California 90059, USA
    Nat Rev Drug Discov 4:713-4. 2005
  22. ncbi Efforts to improve subsequent treatment of cardiovascular risk factors in older patients with diabetes hospitalized for a cardiac event
    Diana Echeverry
    Charles R Drew University School of Medicine and Science, Clinical Center for Research Excellence, University of California, Los Angeles, CA 90059, USA
    Am J Manag Care 11:758-64. 2005
    ..To improve the treatment of risk factors of cardiovascular disease (CVD) for older patients with diabetes after a cardiac event by using a low-literacy reminder card describing these risk factors in community settings...
  23. ncbi Indirect support for the use of supplemental insulin in hospitalized insulin-requiring diabetic patients
    Mayer B Davidson
    Clinical Trials Unit, Charles R. Drew University, 1731 East 120th St, Los Angeles, CA 90059, USA
    Diabetes Care 27:2260-1. 2004
  24. ncbi ImmunoDip: an improved screening method for microalbuminuria
    Mayer B Davidson
    Clinical Trials Unit, Charles R Drew University, Los Angeles, Calif 90059, USA
    Am J Nephrol 24:284-8. 2004
    ..Current screening methods are suboptimal. This study evaluates a new office screening test for microalbuminuria that utilizes a monoclonal antibody against human serum albumin (ImmunoDip)...
  25. ncbi Effective diabetes care by a registered nurse following treatment algorithms in a minority population
    Mayer B Davidson
    Charles R Drew University, Los Angeles, CA 90059, USA
    Am J Manag Care 12:226-32. 2006
    ..To compare usual care with nurse-directed care for patients with diabetes...
  26. ncbi The impact of using a low-literacy patient education tool on process measures of diabetes care in a minority population
    Diana M Echeverry
    Charles R Drew University School of Medicine, Los Angeles, California 90059, USA
    J Natl Med Assoc 95:1074-81. 2003
    ..We conclude that although low-literacy reminder cards did improve the ordering of process measures somewhat, they were not as effective as the utilization of progress forms with specific diabetes-related measures...
  27. ncbi Lowering the criterion for impaired fasting glucose will not provide clinical benefit
    Mayer B Davidson
    Clinical Trials Unit, Charles R. Drew University, Los Angeles, California 90059, USA
    Diabetes Care 26:3329-30. 2003
  28. ncbi Comparison of the glycemic effects of rosiglitazone and pioglitazone in triple oral therapy in type 2 diabetes
    Michael T Tran
    Clinical Center for Research Excellence, Charles R. Drew University, 1731 East 120th Street, Los Angeles, CA 90059, USA
    Diabetes Care 29:1395-6. 2006
  29. ncbi Effect of nurse-directed diabetes care in a minority population
    Mayer B Davidson
    Clinical Trials Unit, Charles R Drew University, Los Angeles, California 90059, USA
    Diabetes Care 26:2281-7. 2003
    ....
  30. ncbi The case for "outsourcing" diabetes care
    Mayer B Davidson
    Clinical Trials Unit, Charles R. Drew University, Los Angeles, California 90059, USA
    Diabetes Care 26:1608-12. 2003
  31. ncbi Have we got the new diagnostic criteria for diabetes and impaired glucose states right? No
    Mayer B Davidson
    Charles R Drew University of Medicine and Science, Clinical Trials Unit, 1731 East 120th Street, Los Angeles, CA 90059, USA
    Curr Diab Rep 2:3-4. 2002
  32. ncbi Counterpoint: the oral glucose tolerance test is superfluous
    Mayer B Davidson
    Clinical Trials Unit, Charles R. Drew University, Los Angeles, California 90059, USA
    Diabetes Care 25:1883-5. 2002
  33. ncbi Revisiting the oral glucose tolerance test criterion for the diagnosis of diabetes
    M B Davidson
    Charles R Drew University of Medicine and Science, Los Angeles, Calif, USA
    J Gen Intern Med 15:551-5. 2000
    ....
  34. ncbi Established therapies for diabetes mellitus
    Stanley H Hsia
    Charles R. Drew University of Medicine and Science, Clinical Trials Unit, Los Angeles, California 90059, USA
    Curr Med Res Opin 18:s13-21. 2002
    ..Newer agents (such as the thiazolidinediones, newer insulin secretagogues, and insulin analogues) will be discussed elsewhere...
  35. ncbi Effect of pharmacological treatment of depression on A1C and quality of life in low-income Hispanics and African Americans with diabetes: a randomized, double-blind, placebo-controlled trial
    Diana Echeverry
    Charles Drew University, Los Angeles, California, USA
    Diabetes Care 32:2156-60. 2009
    ..To determine whether pharmacological treatment of depression in low-income minorities with diabetes improves A1C and quality of life (QOL)...
  36. ncbi Utility of A1C for diabetes screening in the 1999 2004 NHANES population
    Catherine Buell
    Charles R. Drew University, Los Angeles, California 90059, USA
    Diabetes Care 30:2233-5. 2007
  37. ncbi Angiotensin-converting enzyme inhibition for the treatment of moderate to severe diabetic retinopathy in normotensive Type 2 diabetic patients. A pilot study
    Rita Pradhan
    Department of Medicine, Charles R. Drew University, Los Angeles, CA, USA
    J Diabetes Complications 16:377-81. 2002
    ....
  38. ncbi Cost effectiveness of statin therapy for the primary prevention of major coronary events in individuals with type 2 diabetes
    Michael Brandle
    Department of Internal Medicine, Division of Endocrinology and Metabolism, and the Michigan Diabetes Research and Training Center, University of Michigan Health System, Ann Arbor, Michigan 48109, USA
    Diabetes Care 26:1796-801. 2003
    ....
  39. ncbi Thiazolidinediones
    Mayer B Davidson
    N Engl J Med 352:205-7; author reply 205-7. 2005
  40. ncbi Impaired fasting glucose and impaired glucose tolerance: implications for care
    David M Nathan
    Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA
    Diabetes Care 30:753-9. 2007
  41. ncbi Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: update regarding thiazolidinediones: a consensus statement from the American Diabetes Association and the European Association for the Stud
    David M Nathan
    Diabetes Center, Massachusetts General Hospital, Boston, MA 02114, USA
    Diabetes Care 31:173-5. 2008
  42. ncbi A new look at screening and diagnosing diabetes mellitus
    Christopher D Saudek
    Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    J Clin Endocrinol Metab 93:2447-53. 2008
    ..This report reconsiders the criteria for diagnosing diabetes and recommends screening criteria to make case finding easier for clinicians and patients...
  43. ncbi No need for the needle (at first)
    Mayer B Davidson
    Diabetes Care 31:2070-1. 2008
  44. ncbi Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: response to Welschen et al. and Kleefstra et al
    Mayer B Davidson
    Diabetes Care 28:2597; author reply 2597-8. 2005
  45. ncbi Editor's comment: "It ain't necessarily so"
    Mayer B Davidson
    Diabetes Care 25:2116. 2002
  46. ncbi Recommendations for management of diabetes during Ramadan
    Mayer B Davidson
    Diabetes Care 29:745; author reply 746. 2006
  47. ncbi Twice-Daily NPH or mixture insulins versus triple therapy: apples versus oranges: response to Poulsen et al
    Mayer B Davidson
    Diabetes Care 27:1846; author reply 1847-8. 2004
  48. ncbi Type-1 diabetes mellitus with insufficient serum immunoreactive insulin elevation after subcutaneous NPH-insulin injection
    Mayer B Davidson
    Diabetes Res Clin Pract 64:229. 2004
  49. ncbi For the patient. Managing diabetes with cultural sensitivity and self-empowerment
    Catherine A Sarkisian
    Ethn Dis 15:351. 2005
  50. ncbi Triple therapy: definitions, application, and treating to target
    Mayer B Davidson
    Diabetes Care 27:1834-5. 2004
  51. ncbi Starting insulin therapy in type 2 diabetic patients: does it really matter how?
    Mayer B Davidson
    Diabetes Care 28:494-5. 2005
  52. ncbi Early insulin therapy for type 2 diabetic patients: more cost than benefit
    Mayer B Davidson
    Diabetes Care 28:222-4. 2005
  53. ncbi Tests of glycemia
    Mayer B Davidson
    Ann Intern Med 138:517; author reply 517. 2003
  54. ncbi Novel risk factors for atherosclerosis
    Mayer B Davidson
    JAMA 291:301; author reply 301-2. 2004
  55. ncbi Treatment decisions for type 2 diabetes
    Mayer B Davidson
    JAMA 287:1646-7; author reply 1647-8. 2002
  56. ncbi Status of research funded by the American Diabetes Association: year 3
    Mayer B Davidson
    Diabetes Care 25:626. 2002
  57. ncbi Status of research funded by the American Diabetes Association: year 3
    Mayer B Davidson
    Diabetes 51:888. 2002
  58. ncbi Metformin does not suppress thyrotropin
    Mayer B Davidson
    Endocr Pract 14:252-3. 2008
  59. ncbi Status of research funded by the American Diabetes Association--year 4
    Mayer B Davidson
    Diabetes 52:1588. 2003
  60. ncbi Is treatment of insulin resistance beneficial independent of glycemia?
    Mayer B Davidson
    Diabetes Care 26:3184-6. 2003
  61. ncbi Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes
    David M Nathan
    Diabetes Center, Massachusetts General Hospital, Boston, 02114, USA
    Diabetes Care 29:1963-72. 2006
  62. ncbi Metabolic syndrome/insulin resistance syndrome/pre-diabetes: new section in diabetes care
    Mayer B Davidson
    Diabetes Care 26:3179. 2003
  63. ncbi Does the metabolic syndrome exist: response to Grundy
    Mayer B Davidson
    Diabetes Care 29:2565; author reply 2565-6. 2006
  64. ncbi Status of research funding by the American Diabetes Association--5th and final year
    Mayer B Davidson
    Diabetes 53:1403. 2004
  65. ncbi Status of research funded by the American Diabetes Association--year 4
    Mayer B Davidson
    Diabetes Care 26:1940. 2003
  66. ncbi Glycemia and risk for cardiovascular disease
    Mayer B Davidson
    Ann Intern Med 142:227; author reply 227-8. 2005
  67. ncbi Status of research funding by the American Diabetes Association--5th and final year
    Mayer B Davidson
    Diabetes Care 27:1235. 2004
  68. ncbi The effect of disease management programs for patients with diabetes mellitus on processes and outcomes of care
    Mayer B Davidson
    Am J Manag Care 11:585; author reply 585. 2005
  69. ncbi SF-36 and diabetes outcome measures
    Mayer B Davidson
    Diabetes Care 28:1536-7. 2005
  70. ncbi Staying the course--with a few adjustments
    Mayer B Davidson
    Diabetes Care 25:1. 2002